• >>> Scorecard Login
Chelko Consulting Group
  • About
    • Leadership
    • Mission & Maxims
    • Testimonials
  • Services
    • Analytics
    • Strategic Advice
    • Plan Management
    • Vendor Selection
    • High Performance Wellness
    • Exchange Evaluation
    • Eligibility Audits
    • Total Rewards Statements
  • Insights & Resources
    • In Focus Blog
    • COVID-19 Updates
    • Legislative Updates
    • Benefits Roundtable
  • Careers
Select Page
Another Day, Another Shell Game

Another Day, Another Shell Game

Nov 30, 2021 | by Kelly Prymicz, Commentary, Specialty Drug Management

If you’re a plan sponsor, you’re probably familiar with the drug Humira. That’s undoubtedly because it appears toward the top of your list of costliest drugs. Well, that might change soon. Or maybe not. It’s tough to tell. (more…)

Strange Bedfellows: High-Cost Drugs and Peace of Mind

Strange Bedfellows: High-Cost Drugs and Peace of Mind

Nov 29, 2021 | Commentary, Specialty Drug Management

What keeps you awake at night? For a couple years now, we’ve written about the number of mega-expensive new cell and gene therapies in the development pipeline. By “mega,” we generally mean therapies costing more than a million dollars. (more…)

Recent Posts

  • A Question of Transparency
  • How End of COVID-19 Emergency Periods Will Impact Health Plans
  • Let’s Take a Look Under the Hood
  • New Laws Expand Pregnancy and Nursing Accommodations
  • Submission Grace Period Issued for Prescription Drug Reporting
  • IRS Finalizes Deadline Extension for Furnishing ACA Statements
  • ACA 2023 Compliance Checklist
  • PCORI Fee Amount Adjusted for 2023
  • Employee Benefit Plan Limits for 2023
  • No Field of Dreams: Point Solutions Take Work

Categories

  • Actuarial Perspective
  • by Eric Sepanski
  • by Kelly Prymicz
  • by Lucia Vescera
  • by Rick Chelko
  • by Steve Parsons
  • Commentary
  • Community
  • COVID-19 Updates
  • Keeping Score
  • Legislative Updates
  • News
  • Specialty Drug Management

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • January 2018
  • December 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016